Top Pharmaceuticals stocks in Australasia
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
CSLCSL | AU$130.19bn | 32.67 | 1.48% |
EBOEBOS | NZ$6.65bn | 22.31 | 3.3% |
NEUNeuren Pharmaceuticals | AU$2.41bn | 15.31 | n/a |
SIGSigma Healthcare | AU$1.97bn | 295.99 | 0.79% |
CUVClinuvel Pharmaceuticals | AU$720.83m | 23.85 | 0.35% |
MYXMayne Pharma | AU$541.10m | n/a | n/a |
BOTBotanix Pharmaceuticals | AU$348.11m | n/a | n/a |
AFTAFT Pharmaceuticals | NZ$329.28m | 29.88 | 0.23% |
PBPProbiotec | AU$230.96m | 25.41 | 2.46% |
VLSVita Life Sciences | AU$132.54m | 14.17 | 3.83% |
NXSNext Science | AU$126.89m | n/a | n/a |
RCERecce Pharmaceuticals | AU$107.96m | n/a | n/a |
PAAPharmaust | AU$106.61m | n/a | n/a |
VITVitura Health | AU$92.14m | 9.71 | 6.25% |
BIOBiome Australia | AU$74.19m | n/a | n/a |
IHLIncannex Healthcare | AU$65.07m | n/a | n/a |
SPLStarpharma Holdings | AU$53.53m | n/a | n/a |
MVPMedical Developments International | AU$48.76m | n/a | n/a |
LGPLittle Green Pharma | AU$40.51m | n/a | n/a |
IMCImmuron | AU$22.78m | n/a | n/a |